Scientia Clinical Research Limited Sydney   Report issue

For profit Phase 1
Founded: Randwick Australia (2016)

Organization Overview

First Clinical Trial
2017
NCT03272009
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2022

Timeline

NOW
  • Now

Alternative names

Scientia | Scientia Clinical Research | Scientia Clinical Research Limited | Scientia Clinical Research Limited Sydney | Scientia Clinical Research Ltd | Scientia Clinical Research Ltd.

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Fibrosis (Phase 1)

Hepatitis B (Phase 1)

Hepatitis B, Chronic (Phase 1)

Overview

  • Highest Phase: Phase 1
  • # of Trials: 13
  • # of Trial APIs: 17